Prognostic markers articles from across Nature Portfolio
Prognostic markers are biological characteristics that are objectively measured and evaluated to predict the course of a disease or a response to a therapeutic intervention among patients with the same characteristic. Examples include the presence of a particular gene variant, patterns of gene expression or levels of a particular protein in body fluids.
Featured
Advancing neoadjuvant immunotherapy for lung cancerLatest Research and Reviews
-
Research
| Open Access
Functional sugar-free chewing gum infused with spices bolsters antioxidant capacity and phenolic content of saliva
Scientific Reports 13, 4802 -
-
-
Research
| Open Access
Use of laboratory-developed assays in global HIV-1 treatment-monitoring and research
Scientific Reports 13, 4578 -
-
Research
| Open Access
Pulmonary vessel volume in idiopathic pulmonary fibrosis compared with healthy controls aged > 50 years
Scientific Reports 13, 4422
Functional sugar-free chewing gum infused with spices bolsters antioxidant capacity and phenolic content of saliva
A systematic review and meta-analysis of brain volume abnormalities in disruptive behaviour disorders, antisocial personality disorder and psychopathy
One year follow-up on a randomized study investigating serratus anterior muscle and pectoral nerves type I block to reduced neuropathic pain descriptors after mastectomy
Use of laboratory-developed assays in global HIV-1 treatment-monitoring and research
Optical coherence tomography angiography measurements in Parkinson’s disease: A systematic review and meta-analysis
Pulmonary vessel volume in idiopathic pulmonary fibrosis compared with healthy controls aged > 50 years
Appropriate duration of antidepressant medications for prevention of depressive relapse and the impact of life stage
Cellular senescence: is the problem a solution for muscle repair?
Early MRD predicts disease recurrence and benefit from adjuvant chemotherapy in CRC
Wearables and AI better predict the progression of muscular dystrophy
Postoperative circulating tumor DNA could guide CRC adjuvant treatment